Similar companies
Income Statement (EUR)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 11.4B | 2.4% |
Gross Profit | 7.97B | 3.8% |
Cost of Revenue | 3.41B | 0.8% |
Operating expense | 9.1B | 67% |
Net Income | 1.11B | 1.8% |
Balance Sheet (EUR)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 130B | 0% |
Total Liabilities | 56.8B | 0% |
Total Equity | 72.7B | 2.2% |
Shares Outstanding | 1.25B | 49.9% |
Cash Flow (EUR)
Q2 '24 | QoQ |
---|
Financial Highlights for Sanofi in Q2 '24
Sanofi reported a revenue of 11.4B, which is a 2.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 7.97B, marking a 3.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 3.41B, a -0.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 9.1B, showing a 67% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.11B, showing a -1.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Sanofi faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.